Mangoceuticals (MGRX) announced the official launch of PeachesRx, a women’s health and wellness brand focused on providing cutting-edge, convenient treatments tailored to women’s unique health needs. These women’s health and wellness products will be made available via a secure telemedicine platform. PeachesRx will debut with a strong focus on compounded GLP-1 receptor agonists-a class of medications proven to aid weight loss by regulating appetite and glucose metabolism. The global women’s health market was valued at $49.33B in 2024 and is projected to reach $68.53B by 2030, growing at a 5.1% CAGR.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRX:
- Mangoceuticals advances research on patented respiratory illness technology
- Mangoceuticals Expands COO Role and Increases Compensation
- Mangoceuticals advances H1N1 study conducted by Vipragen
- Mangoceuticals executes exclusive distribution agreement with Propre
- Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments